Cargando…
Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338084/ https://www.ncbi.nlm.nih.gov/pubmed/28264683 http://dx.doi.org/10.1186/s12941-017-0184-2 |
_version_ | 1782512502274260992 |
---|---|
author | Franco-Paredes, Carlos Chastain, Daniel B. Rodriguez-Morales, Alfonso J. Marcos, Luis A. |
author_facet | Franco-Paredes, Carlos Chastain, Daniel B. Rodriguez-Morales, Alfonso J. Marcos, Luis A. |
author_sort | Franco-Paredes, Carlos |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5338084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53380842017-03-10 Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? Franco-Paredes, Carlos Chastain, Daniel B. Rodriguez-Morales, Alfonso J. Marcos, Luis A. Ann Clin Microbiol Antimicrob Editorial BioMed Central 2017-03-06 /pmc/articles/PMC5338084/ /pubmed/28264683 http://dx.doi.org/10.1186/s12941-017-0184-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Editorial Franco-Paredes, Carlos Chastain, Daniel B. Rodriguez-Morales, Alfonso J. Marcos, Luis A. Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? |
title | Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? |
title_full | Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? |
title_fullStr | Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? |
title_full_unstemmed | Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? |
title_short | Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? |
title_sort | cryptococcal meningoencephalitis in hiv/aids: when to start antiretroviral therapy? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338084/ https://www.ncbi.nlm.nih.gov/pubmed/28264683 http://dx.doi.org/10.1186/s12941-017-0184-2 |
work_keys_str_mv | AT francoparedescarlos cryptococcalmeningoencephalitisinhivaidswhentostartantiretroviraltherapy AT chastaindanielb cryptococcalmeningoencephalitisinhivaidswhentostartantiretroviraltherapy AT rodriguezmoralesalfonsoj cryptococcalmeningoencephalitisinhivaidswhentostartantiretroviraltherapy AT marcosluisa cryptococcalmeningoencephalitisinhivaidswhentostartantiretroviraltherapy |